| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.099 | 0.07 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |